PODD - Insulet Corp Stock Price, Fair Value and News

187.27USD+1.89 (+1.02%)Market Closed

Market Summary

USD187.27+1.89

Market Closed

1.02%

PODD Alerts

Big jump in Earnings (Y/Y)

PODD Stock Price

View Fullscreen

PODD RSI Chart

PODD Valuation

Market Cap

13.1B

Price/Earnings (Trailing)

56.05

Price/Sales (Trailing)

7.37

EV/EBITDA

38.46

Price/Free Cashflow

90.08

PODD Price/Sales (Trailing)

PODD Profitability

EBT Margin

13.75%

Return on Equity

29.59%

Return on Assets

8.92%

Free Cashflow Yield

1.11%

PODD Fundamentals

PODD Revenue

Revenue (TTM)

1.8B

Rev. Growth (Yr)

23.35%

Rev. Growth (Qtr)

-13.36%

PODD Earnings

Earnings (TTM)

234.0M

Earnings Growth (Yr)

116.39%

Earnings Growth (Qtr)

-50.15%

Breaking Down PODD Revenue

Last 7 days

12.9%

Last 30 days

12.6%

Last 90 days

-2.0%

Trailing 12 Months

-38.2%

How does PODD drawdown profile look like?

PODD Financial Health

Current Ratio

3.74

Debt/Equity

1.72

Debt/Cashflow

0.17

PODD Investor Care

Shares Dilution (1Y)

0.49%

Diluted EPS (TTM)

3.33

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.8B	0	0	0
2023	1.4B	1.5B	1.6B	1.7B
2022	1.1B	1.2B	1.2B	1.3B
2021	958.7M	995.6M	1.0B	1.1B
2020	776.6M	825.8M	867.7M	904.4M
2019	599.8M	652.7M	693.7M	738.2M
2018	485.7M	500.1M	529.4M	563.8M
2017	387.5M	409.9M	436.8M	463.8M
2016	297.0M	323.7M	347.2M	367.0M
2015	224.1M	227.1M	238.5M	263.9M
2014	245.1M	242.6M	241.5M	231.3M
2013	221.0M	230.0M	236.4M	247.1M
2012	171.8M	190.6M	200.7M	211.4M
2011	104.4M	113.7M	132.8M	152.3M
2010	73.8M	81.5M	89.2M	97.0M
2009	0	0	0	66.0M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Insulet Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 01, 2024	chadwick ana maria	acquired	-	-	13,214	evp, cfo & treasurer
Feb 28, 2024	petrovic shacey	sold	-1,891,340	162	-11,609	-
Feb 28, 2024	hollingshead james	sold (taxes)	-148,549	163	-908	president and ceo
Feb 28, 2024	budden lauren	sold (taxes)	-38,118	163	-233	interim cfo and treasurer
Feb 28, 2024	petrovic shacey	acquired	1,069,300	92.11	11,609	-
Feb 28, 2024	manea dan	sold (taxes)	-27,484	163	-168	svp, chief hr officer
Feb 28, 2024	kapples john w.	sold (taxes)	-43,026	163	-263	svp and general counsel
Feb 28, 2024	cousin laetitia	sold (taxes)	-10,143	163	-62.00	svp, reg, quality & compliance
Feb 28, 2024	field mark n	sold (taxes)	-21,922	163	-134	svp & chief technology officer
Feb 28, 2024	singh prem	sold (taxes)	-14,724	163	-90.00	svp, global operations

Which funds bought or sold PODD recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 17, 2024	Plato Investment Management Ltd	added	1,574	960,138	1,038,680	0.11%
May 17, 2024	Kozak & Associates, Inc.	sold off	-	-	-	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-0.39	-5,043,820	18,618,500	0.02%
May 16, 2024	JANE STREET GROUP, LLC	reduced	-90.77	-1,745,180	156,319	-%
May 16, 2024	Garner Asset Management Corp	sold off	-100	-14,630	-	-%
May 16, 2024	Creekmur Asset Management LLC	new	-	4,285	4,285	-%
May 16, 2024	Pineridge Advisors LLC	sold off	-100	-5,208	-	-%
May 16, 2024	Motley Fool Asset Management LLC	added	7.13	-43,496	239,446	0.01%
May 16, 2024	COMERICA BANK	reduced	-32.98	-10,132,500	11,400,800	0.05%
May 16, 2024	Grandeur Peak Global Advisors, LLC	added	6.23	-1,465,780	7,645,640	0.61%

Are Funds Buying or Selling PODD?

Are funds buying PODD calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PODD

No. of Funds

PODD Alerts

Big jump in Earnings (Y/Y)

Unveiling Insulet Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	11.50%	8,029,608	SC 13G/A
Feb 09, 2024	capital world investors	3.3%	2,312,283	SC 13G/A
Feb 09, 2024	capital research global investors	13.6%	9,476,623	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Feb 08, 2024	wellington management group llp	4.87%	3,401,606	SC 13G/A
Jan 25, 2024	blackrock inc.	8.7%	6,102,546	SC 13G/A
Oct 13, 2023	fmr llc	-	0	SC 13G/A
Oct 10, 2023	fil ltd	-	0	SC 13G/A
Apr 10, 2023	vanguard group inc	11.36%	7,903,404	SC 13G/A
Feb 13, 2023	capital world investors	5.9%	4,097,334	SC 13G/A

Recent SEC filings of Insulet Corp

View All Filings

Date Filed	Form Type	Document
May 10, 2024	10-Q	Quarterly Report
May 09, 2024	8-K	Current Report
May 02, 2024	4	Insider Trading
Apr 25, 2024	3	Insider Trading
Apr 09, 2024	DEF 14A	DEF 14A
Apr 09, 2024	DEFA14A	DEFA14A
Mar 20, 2024	8-K	Current Report
Mar 01, 2024	8-K	Current Report
Feb 29, 2024	4	Insider Trading
Feb 29, 2024	4	Insider Trading

Peers (Alternatives to Insulet Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.83%	-87.10%	-0.09	0.28	5.77%	8.23%

Insulet Corp News

Latest updates

Insulet Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-13.4%	442	510	433	397	358	370	341	299	295	308	276	263	252	246	234	226	198	209	192	177	160
Gross Profit	-15.1%	307	361	293	265	241	217	188	190	210	213	189	183	168	161	152	143	127	134	123	116	107
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	116	106	109	99.00
S&GA Expenses	-6.2%	200	213	181	179	163	144	140	174	129	122	118	116	111	130	89.00	81.00	84.00	81.00	75.00	76.00	67.00
R&D Expenses	19.5%	50.00	42.00	58.00	55.00	50.00	50.00	45.00	43.00	43.00	42.00	38.00	40.00	41.00	38.00	39.00	34.00	36.00	36.00	31.00	33.00	33.00
EBITDA Margin	9.2%	0.20*	0.18*	0.15*	0.11*	0.07*	0.07*	0.15*	0.15*	0.15*	0.13*	-0.02*	-0.02*	-	-	-	-	-	-	-	-	-
Interest Expenses	-43.4%	11.00	19.00	10.00	-2.40	-2.90	26.00	9.00	-8.30	-8.90	108	-16.30	-16.40	-13.40	-12.50	-11.40	-11.10	-10.10	-9.40	-7.70	-5.80	-4.80
Income Taxes	-24.4%	3.00	5.00	2.00	1.00	1.00	5.00	-0.50	-1.10	2.00	4.00	3.00	-3.40	0.00	-1.40	2.00	3.00	-0.50	2.00	0.00	1.00	0.00
Earnings Before Taxes	-49.1%	55.00	108	54.00	29.00	25.00	22.00	-5.70	-36.10	29.00	33.00	15.00	-28.40	0.00	-18.50	13.00	17.00	-2.60	7.00	1.00	2.00	5.00
EBT Margin	8.8%	0.14*	0.13*	0.08*	0.05*	0.00*	0.01*	0.02*	0.04*	0.04*	0.02*	-0.03*	-0.03*	-	-	-	-	-	-	-	-	-
Net Income	-50.1%	52.00	103	52.00	27.00	24.00	17.00	-5.20	-35.00	28.00	29.00	13.00	-25.00	-	-17.10	12.00	14.00	-2.10	5.00	1.00	1.00	4.00
Net Income Margin	8.1%	0.13*	0.12*	0.08*	0.04*	0.00*	0.00*	0.01*	0.03*	0.04*	0.02*	-0.03*	-0.03*	-	-	-	-	-	-	-	-	-
Free Cashflow	311.9%	66.00	16.00	36.00	28.00	-10.00	-13.70	26.00	11.00	-26.50	-57.30	-53.10	-1.60	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	1.4%	2,624	2,588	2,468	2,386	2,289	2,251	2,166	2,114	2,069	2,049	1,999	1,924	1,840	1,873	1,711	1,627	1,108	1,143	1,268	978	953
Current Assets	2.2%	1,618	1,583	1,471	1,422	1,330	1,314	1,329	1,309	1,285	1,330	1,307	1,253	1,192	1,249	1,160	1,086	541	591	794	499	496
Cash Equivalents	6.7%	751	704	685	660	636	690	737	724	725	806	871	869	836	922	838	779	201	214	420	120	129
Inventory	7.0%	431	403	411	411	386	347	328	320	315	303	259	198	170	154	125	104	96.00	101	90.00	85.00	74.00
Net PPE	-	-	-	-	602	597	600	553	536	538	537	515	506	498	479	449	423	412	399	356	334	300
Goodwill	0%	52.00	52.00	52.00	52.00	52.00	52.00	52.00	52.00	52.00	40.00	40.00	40.00	40.00	40.00	40.00	40.00	40.00	40.00	40.00	40.00	40.00
Liabilities	-1.2%	1,833	1,856	1,860	1,832	1,786	1,775	1,738	1,691	1,623	1,493	1,501	1,465	1,255	1,269	1,116	1,063	1,049	1,067	1,118	728	729
Current Liabilities	-4.2%	432	451	451	425	383	365	334	279	215	229	229	213	186	208	175	134	130	158	113	106	114
Long Term Debt	-0.3%	1,363	1,366	1,371	1,369	1,369	1,374	1,380	1,385	1,391	1,249	1,257	1,235	1,052	1,044	922	910	899	888	986	607	600
LT Debt, Current	-21.3%	39.00	49.00	50.00	29.00	28.00	28.00	27.00	26.00	26.00	25.00	29.00	21.00	16.00	16.00	-	-	-	-	-	-	-
LT Debt, Non Current	-	-	-	-	1,369	1,369	1,374	1,380	1,385	1,391	1,249	1,257	1,235	1,052	1,044	922	910	899	888	986	607	600
Shareholder's Equity	7.9%	791	733	608	554	503	476	428	422	447	556	498	459	585	604	595	563	59.00	76.00	151	250	224
Retained Earnings	13.6%	-326	-378	-481	-533	-560	-584	-601	-596	-561	-649	-678	-691	-666	-666	-649	-660	-675	-672	-676	-677	-679
Additional Paid-In Capital	1.4%	1,118	1,103	1,081	1,071	1,047	1,041	1,022	1,011	996	1,208	1,180	1,150	1,248	1,264	1,245	1,228	738	749	832	930	906
Shares Outstanding	0.2%	70.00	70.00	70.00	70.00	70.00	70.00	69.00	69.00	69.00	68.00	69.00	66.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	20,100	-	-	-	15,100	-	-	-	18,800	-	-	-	12,700	-	-	-	7,200	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	93.8%	87,600	45,200	56,000	44,000	500	50,700	56,700	25,300	-13,700	-25,500	-25,800	18,300	-35,100	17,000	44,200	26,400	-3,600	46,900	31,100	13,900	6,500
Share Based Compensation	12.7%	14,200	12,600	10,500	13,100	12,100	11,200	9,000	11,200	9,500	8,600	8,200	9,000	8,600	15,600	6,600	5,800	7,900	8,000	6,600	8,300	5,800
Cashflow From Investing	24.1%	-24,000	-31,600	-22,600	-23,100	-42,100	-88,400	-33,900	-21,900	-46,900	-36,400	-12,200	-11,400	-22,700	-69,300	2,700	67,200	13,400	-54,000	12,200	-39,400	7,600
Cashflow From Financing	-740.9%	-14,100	2,200	-6,900	3,200	-12,100	-14,500	-3,900	-1,600	-20,300	-1,500	42,200	28,400	-28,400	130,100	10,500	483,900	-19,000	-202,400	258,200	16,200	1,500
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	300

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

PODD Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue	$ 441.7	$ 358.1
Cost of revenue	134.9	117.6
Gross profit	306.8	240.5
Research and development expenses	50.2	50.1
Selling, general and administrative expenses	199.7	162.7
Operating income	56.9	27.7
Interest expense, net	(10.7)	(9.4)
Interest income	9.4	6.5
Other expense, net	(0.7)	(0.2)
Income before income taxes	54.9	24.6
Income tax expense	(3.4)	(0.8)
Net income	$ 51.5	$ 23.8
Earnings per share:
Basic (in dollars per share)	$ 0.74	$ 0.34
Diluted (in dollars per share)	$ 0.73	$ 0.34
Weighted-average number of common shares outstanding (in thousands):
Basic (in shares)	69,957	69,583
Diluted (in shares)	73,741	70,096
Nonrelated Party
Revenue	$ 329.9	$ 261.3
Related Party
Revenue	$ 111.8	$ 96.8

PODD Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 751.2	$ 704.2
Inventories	430.6	402.6
Prepaid expenses and other current assets	116.1	116.4
Total current assets	1,618.4	1,582.9
Property, plant and equipment, net	667.7	664.9
Other intangible assets, net	98.5	98.7
Goodwill	51.7	51.7
Other assets (includes $29.4 and $31.3 at fair value)	187.7	190.0
Total assets	2,624.0	2,588.2
Current Liabilities
Accounts payable	75.9	19.2
Current portion of long-term debt	38.9	49.4
Total current liabilities	432.4	451.2
Long-term debt, net	1,362.6	1,366.4
Other liabilities	38.3	37.9
Total liabilities	1,833.3	1,855.5
Commitments and contingencies (Note 12)
Stockholders’ Equity
Preferred stock, $.001 par value, 5,000,000 authorized; none issued and outstanding	0.0	0.0
Common stock, $.001 par value, 100,000,000 authorized; 70,020,202 and 69,907,289 issued and outstanding	0.1	0.1
Additional paid-in capital	1,117.6	1,102.6
Accumulated deficit	(326.5)	(378.0)
Accumulated other comprehensive (loss) income	(0.5)	8.0
Total stockholders’ equity	790.7	732.7
Total liabilities and stockholders’ equity	2,624.0	2,588.2
Nonrelated Party
Current Assets
Accounts receivable, net	234.1	240.2
Current Liabilities
Accrued expenses and other current liabilities	308.6	373.7
Related Party
Current Assets
Accounts receivable, net	86.4	119.5
Current Liabilities
Accrued expenses and other current liabilities	$ 9.0	$ 8.9

About Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

CEO	Dr. James R. Hollingshead Ph.D.
WEBSITE	insulet.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	2600

Insulet Corp Frequently Asked Questions

What is the ticker symbol for Insulet Corp? What does PODD stand for in stocks?

PODD is the stock ticker symbol of Insulet Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Insulet Corp (PODD)?

As of Fri May 17 2024, market cap of Insulet Corp is 13.12 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PODD stock?

You can check PODD's fair value in chart for subscribers.

What is the fair value of PODD stock?

You can check PODD's fair value in chart for subscribers. The fair value of Insulet Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Insulet Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PODD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Insulet Corp a good stock to buy?

The fair value guage provides a quick view whether PODD is over valued or under valued. Whether Insulet Corp is cheap or expensive depends on the assumptions which impact Insulet Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PODD.

What is Insulet Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, PODD's PE ratio (Price to Earnings) is 56.05 and Price to Sales (PS) ratio is 7.37. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PODD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Insulet Corp's stock?

In the past 10 years, Insulet Corp has provided 0.188 (multiply by 100 for percentage) rate of return.